Evidence map›Paper›PMID 22110129›Full record

ArticleThe Journal of biological chemistry2012

Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart.

Matthew R Mysliwiec, Clayton D Carlson, Josh Tietjen, Holly Hung, Aseem Z Ansari, Youngsook Lee

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. The Many Faces of SetDB1.Epigenomes · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Roles of Histone Lysine Methyltransferases in Heart Development and Disease.Journal of cardiovascular development and disease · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. DNA Methylation Signature forInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. JARID2 haploinsufficiency is associated with a clinically distinct neurodevelopmental syndrome.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  15. Review
  16. Endothelial-Myocardial Angiocrine Signaling in Heart Development.Frontiers in cell and developmental biology · 2021
    Review
  17. Article
  18. Review
  19. Myocardial-specific ablation ofThe Journal of biological chemistry · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew R MysliwiecDepartment of Cellular and Regenerative Biology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Clayton D Carlson
Josh Tietjen
Holly Hung
Aseem Z Ansari
Youngsook Lee

Funding

Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
Roles of transcription factors in cardiac developmentR01HL067050 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI LEE, YOUNGSOOK · 2002 to 2009
$2.7M
NHGRI NIH HHS 5T32HG002760NHGRI NIH HHS T32 HG002760NHLBI NIH HHS HL067050NHLBI NIH HHS R01 HL067050PHS HHS NIGMS069420
6 · The paper itself

Abstract

Jarid2/Jumonji, the founding member of the Jmj factor family, critically regulates various developmental processes, including cardiovascular development. The Jmj family was identified as histone demethylases, indicating epigenetic regulation by Jmj proteins. Deletion of Jarid2 in mice resulted in cardiac malformation and increased endocardial Notch1 expression during development. Although Jarid2 has been shown to occupy the Notch1 locus in the developing heart, the precise molecular role of Jarid2 remains unknown. Here we show that deletion of Jarid2 results in reduced methylation of lysine 9 on histone H3 (H3K9) at the Notch1 genomic locus in embryonic hearts. Interestingly, SETDB1, a histone H3K9 methyltransferase, was identified as a putative cofactor of Jarid2 by yeast two-hybrid screening, and the physical interaction between Jarid2 and SETDB1 was confirmed by coimmunoprecipitation experiments. Concurrently, accumulation of SETDB1 at the site of Jarid2 occupancy was significantly reduced in Jarid2 knock out (KO) hearts. Employing genome-wide approaches, putative Jarid2 target genes regulated by SETDB1 via H3K9 methylation were identified in the developing heart by ChIP-chip. These targets are involved in biological processes that, when dysregulated, could manifest in the phenotypic defects observed in Jarid2 KO mice. Our data demonstrate that Jarid2 functions as a transcriptional repressor of target genes, including Notch1, through a novel process involving the modification of H3K9 methylation via specific interaction with SETDB1 during heart development. Therefore, our study provides new mechanistic insights into epigenetic regulation by Jarid2, which will enhance our understanding of the molecular basis of other organ development and biological processes.

Indexed as

AnimalsEpigenesis, GeneticFemaleGene Expression Regulation, DevelopmentalGenome-Wide Association StudyHeartHistone-Lysine N-MethyltransferaseHistonesMaleMethylationMiceMice, KnockoutMuscle ProteinsNerve Tissue ProteinsPolycomb Repressive Complex 2Protein MethyltransferasesHistone-Lysine N-MethyltransferaseHistonesJarid2 protein, mouseMuscle ProteinsNerve Tissue ProteinsNotch1 protein, mousePolycomb Repressive Complex 2Protein MethyltransferasesReceptor, Notch1Repressor ProteinsSETDB1 protein, mouse

Identifiers

PMID22110129
PMCPMC3256911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.